World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

RECURRENT SEIZURES IN PATIENTS SEEKING LOADING DOSE OF MGSO4 IN ECLAMPSIA

Dr. Tayyaba Shakeel*, Dr. Sana Shakeel and Dr. Sidra Hafeez

ABSTRACT

Background: Hypertensive disorders such as eclampsia is significant contributor to maternal and perinatal mortality and morbidity worldwide particularly in the developing countries. This study was done to determine the frequency of recurrent seizures in patients seeking loading dose of MgSO4 only in eclampsia. Materials & Method: Pregnant ladies (n = 114) of any parity, 15-35 years old having more than 20 weeks gestational amenorrhea from last menstrual period were included in our study. Patients admitted with eclampsia were examined for recurrent seizures. Frequency of recurrent seizures with loading dose of mgso4 was noted till 48 hours of receiving loading dose of MgSO4. However if there was a repeat fit with loading dose of MgSO4 then an additional 2 gms. MgSO4 was given intravenously and shifted to maintenance regimen. Results; Mean age of our study cases was noted to be 29.75 ± 4.56 years (with minimum age of our patients was 22 years while maximum age was 35 years). Mean parity of our study cases was noted to be 2.03 ± 1.31. Majority of our study cases i.e. 64 (56.1%) had parity less than 3 and gravidity less than 4 was noted in 82 (71.9%) of our study cases. Mean gestational age of our study cases was noted to be 30.80 ± 4.90 weeks (with minimum gestational age was 22 weeks and maximum gestational age was 38 weeks). Mean body mass index (BMI) of our study cases was noted to be 24.67 ± 3.02 kg/m2 and obesity was noted in 25 (21.9%) of our study cases. Mean number of seizures (before start of therapy) was 6.46 ± 3.21 (with minimum no. of seizures was 3 while maximum no. of seizures were noted to be 15). Recurrence of seizures was noted in 11 (9.6%) of our study cases. Conclusion; Our study results have shown that recurrence of seizures was quite low with loading dose of magnesium sulphate. It is safe, effective and reliable therapy in controlling seizures in eclampsia. Provision of loading dose of MgSO4 to these patients will not only reduce painful intramuscular injections but also helpful to reduce related costs. So use of loading dose of MgSO4 regimen is recommended of our group of patients as most of our patients are poor.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR